Article History
Received: 3 July 2018
Revised: 9 August 2018
Accepted: 14 August 2018
First Online: 20 September 2018
Competing interests
: Dr. Warraich declares no competing interests. Dr. Califf is employed as a scientific advisor by Verily Life Sciences (Alphabet), and reports receiving personal fees from Merck. Dr. Krumholz is the founder of Hugo, a personal health information platform, and is a recipient of research agreements from Medtronic and from Johnson & Johnson (Janssen) through Yale University to develop methods of clinical trial data-sharing; is the recipient of a grant from the US Food and Drug Administration and Medtronic through Yale University to develop methods for post-market surveillance of medical devices; works under contract with the US Centers for Medicare & Medicaid Services to develop and maintain performance measures; chairs a cardiac scientific advisory board for UnitedHealth; is a participant/participant representative of the IBM Watson Health Life Sciences Board; and is a member of the advisory board for Element Science and the physician advisory board for Aetna. Dr. Califf is employed as a scientific advisor by Verily Life Sciences (Alphabet). Dr. Krumholz is the founder of Hugo, a personal health information platform.